{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:51:08Z","timestamp":1791280268780,"version":"4.1.0"},"reference-count":54,"publisher":"Impact Journals, LLC","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,6,28]]},"DOI":"10.18632\/oncotarget.9537","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T15:17:14Z","timestamp":1464016634000},"page":"39916-39930","source":"Crossref","is-referenced-by-count":157,"title":["Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Gu\u00e9rin therapy in bladder cancer"],"prefix":"10.18632","volume":"7","author":[{"given":"Renate","family":"Pichler","sequence":"first","affiliation":[{"name":"Department of Urology, Division of Experimental Urology, Medical University of Innsbruck, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Fritz","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Zavadil","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of General Pathology, Medical University of Innsbruck, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Sch\u00e4fer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of General Pathology, Medical University of Innsbruck, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Culig","sequence":"additional","affiliation":[{"name":"Department of Urology, Division of Experimental Urology, Medical University of Innsbruck, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brunner","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of General Pathology, Medical University of Innsbruck, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,21]]},"reference":[{"key":"1","first-page":"561","article-title":"Contribution a l'etude du bacilli tuberculuex bilie","volume":"9","author":"Negre","year":"1921","journal-title":"Ann Inst Pasteur"},{"key":"2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Bruce","year":"1976","journal-title":"J Urol"},{"key":"3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"European Association of Urology. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"Roupr\u00eat","year":"2013","journal-title":"Eur Urol"},{"key":"4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eururo.2005.03.021","article-title":"Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor","volume":"48","author":"Villavicencio","year":"2005","journal-title":"Eur Urol"},{"key":"5","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.juro.2006.11.090","article-title":"Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer","volume":"177","author":"Dalbagni","year":"2007","journal-title":"J Urol"},{"key":"6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.juro.2006.03.038","article-title":"Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era","volume":"176","author":"Volkmer","year":"2006","journal-title":"J Urol"},{"key":"7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.eururo.2014.11.031","article-title":"Therapeutic options in high-risk non-muscle-invasive bladder cancer during the current worldwide shortage of bacille Calmette-Gu\u00e9rin","volume":"67","author":"Witjes","year":"2015","journal-title":"Eur Urol"},{"key":"8","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.3390\/cancers3033055","article-title":"Immunotherapy for urothelial carcinoma. Current status and perspectives","volume":"3","author":"Tsukamoto","year":"2011","journal-title":"Cancers"},{"key":"9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2249.2012.04614.x","article-title":"Is interferon-gamma the right marker for bacille Calmette-Gu\u00e9rin-induced immune protection? The missing link in our understanding of tuberculosis immunology","volume":"169","author":"Abebe","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.urolonc.2009.06.002","article-title":"A disproportion of TH1\/TH2 cytokines with predominance of TH2, in urothelial carcinoma of bladder","volume":"29","author":"Sharma","year":"2011","journal-title":"Urol Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jcla.21532","article-title":"Alterations of dendritic cell subsets and TH1\/TH2 cytokines in the peripheral circulation of patients with superficial transitional cell carcinoma of the bladder","volume":"26","author":"Yuhai","year":"2012","journal-title":"J Clin Lab Anal"},{"key":"12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0394632015584733","article-title":"Immunohistochemical pattern of T lymphocytes population within bilharzial-associated bladder neoplasm microenvironment","volume":"28","author":"Badawi","year":"2015","journal-title":"Int J Immunopathol Pharmacol"},{"key":"13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.4161\/onci.20640","article-title":"Blocking IL-10 enhances bacillus Calmette-Gu\u00e9rin induced T helper Type 1 immune responses and anti-bladder cancer immunity","volume":"1","author":"Luo","year":"2012","journal-title":"Oncoimmunology"},{"key":"14","article-title":"Development of Predictive Value of Urinary Cytokine Profile Induced During Intravesical Bacillus Calmette-Gu\u00e9rin Instillations for Bladder Cancer","author":"Scotet","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00262-003-0384-9","article-title":"Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu\u00e9rin immunotherapy for carcinomaof the bladder","volume":"52","author":"Naito","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ijc.11352","article-title":"Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Gu\u00e9rin response of superficial bladder cancer during induction course and maintenance therapy","volume":"107","author":"Chopin","year":"2003","journal-title":"Int J Cancer"},{"key":"17","first-page":"45","article-title":"Predicting response to bacillus Calmette-Gu\u00e9rin (BCG) in patients with carcinomaof the bladder","volume":"32","author":"Lee","year":"2014","journal-title":"Urol Oncol"},{"key":"18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-32-87","article-title":"Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer","volume":"32","author":"Pantano","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2011.09.026","article-title":"Markers predicting response to bacillus Calmette-Gu\u00e9rin immunotherapy in high-risk bladder cancer patients: a systematic review","volume":"61","author":"Zwarthoff","year":"2012","journal-title":"Eur Urol"},{"key":"20","article-title":"Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Gu\u00e9rin","author":"Dinney","year":"2015","journal-title":"Eur Urol"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7024","article-title":"Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence","author":"Carmignani","year":"2016","journal-title":"Oncotarget"},{"key":"22","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1464-410X.2010.10020.x","article-title":"FOXP3 and survival in urinary bladder cancer","volume":"108","author":"Winqvist","year":"2011","journal-title":"BJU Int"},{"key":"23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00345-015-1615-3","article-title":"The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer","volume":"34","author":"Slotta-Huspenina","year":"2016","journal-title":"World J Urol"},{"key":"24","doi-asserted-by":"crossref","first-page":"e0133552","DOI":"10.1371\/journal.pone.0133552","article-title":"Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer","volume":"10","author":"Bostr\u00f6m","year":"2015","journal-title":"PLoS One"},{"key":"25","first-page":"791","article-title":"Infiltration of CD3and CD68cells in bladder cancer is subtype specific and interacts the outcome of patients with muscle-invasive tumors","volume":"32","author":"H\u00f6glund","year":"2014","journal-title":"Urol Oncol"},{"key":"26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00345-012-0974-2","article-title":"First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival","volume":"30","author":"Hartmann","year":"2012","journal-title":"World J Urol"},{"key":"27","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1073\/pnas.0611618104","article-title":"CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma","volume":"104","author":"Sato","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"28","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0022-5347(05)65522-X","article-title":"T helper 1\/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancer","volume":"166","author":"Chopin","year":"2001","journal-title":"J Urol"},{"key":"29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1043-4666(02)00490-8","article-title":"Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect","volume":"21","author":"O'Donnell","year":"2003","journal-title":"Cytokine"},{"key":"30","first-page":"137ra72","article-title":"Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer","volume":"4","author":"Albert","year":"2012","journal-title":"Sci Transl Med"},{"key":"31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1442-2042.1997.tb00143.x","article-title":"Immunohistochemical study of tumor-infiltrating lymphocytes before and after intravesical bacillus Calmette-Gu\u00e9rin treatment for superficial bladder cancer","volume":"4","author":"Kitagawa","year":"1997","journal-title":"Int J Urol"},{"key":"32","first-page":"865684","article-title":"Tumor and microenvironment modification during progression of murine orthotopic bladder cancer","volume":"2011","author":"Mahendran","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"33","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.4049\/jimmunol.172.11.7200","article-title":"Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment","volume":"172","author":"Totterman","year":"2004","journal-title":"J Immunol"},{"key":"34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.rmed.2003.12.003","article-title":"Analysis of local T lymphocyte subsets upon stimulation with intravesical BCG: a model to study tuberculosis immunity","volume":"98","author":"Sanduzzi","year":"2004","journal-title":"Respir Med"},{"key":"35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-010-0987-8","article-title":"An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer","volume":"127","author":"Green","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/JTO.0b013e3181d60fd7","article-title":"Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer","volume":"5","author":"Tanemoto","year":"2010","journal-title":"J Thorac Oncol"},{"key":"37","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1200\/JCO.2006.09.4565","article-title":"Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection","volume":"25","author":"Tang","year":"2007","journal-title":"J Clin Oncol"},{"key":"38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00262-014-1651-7","article-title":"Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma","volume":"64","author":"Mitchell","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.juro.2006.08.078","article-title":"Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines","volume":"177","author":"T\u00f6tterman","year":"2007","journal-title":"J Urol"},{"key":"40","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/ijc.28233","article-title":"Antitumor T cell responses in bladder cancer are directed against a limited set of antigens and are modulated by regulatory T cells and routine treatment approaches","volume":"133","author":"Beckhove","year":"2013","journal-title":"Int J Cancer"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7199","article-title":"Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal","author":"Slominski","year":"2016","journal-title":"Oncotarget"},{"key":"42","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1128\/JVI.79.12.7860-7867.2005","article-title":"T cells with a CD4+CD25+ regulatory phenotype suppressproliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection","volume":"79","author":"Thimme","year":"2005","journal-title":"J Virol"},{"key":"43","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.175.11.7264","article-title":"Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance","volume":"175","author":"Hill","year":"2005","journal-title":"J Immunol"},{"key":"44","doi-asserted-by":"crossref","first-page":"13082","DOI":"10.1128\/JVI.78.23.13082-13089.2004","article-title":"CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1","volume":"78","author":"Rouse","year":"2004","journal-title":"J Virol"},{"key":"45","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/eji.200737888","article-title":"Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis","volume":"38","author":"Kirman","year":"2008","journal-title":"Eur J Immunol"},{"key":"46","doi-asserted-by":"crossref","first-page":"16508","DOI":"10.1074\/jbc.M114.558098","article-title":"Small molecule-directed immunotherapy against recurrent infection by Mycobacterium tuberculosis","volume":"289","author":"Das","year":"2014","journal-title":"J Biol Chem"},{"key":"47","doi-asserted-by":"crossref","first-page":"33404","DOI":"10.1074\/jbc.M114.600452","article-title":"Simultaneous inhibition of T helper 2 and T regulatory cell differentiation by small molecules enhances Bacillus Calmette-Guerin vaccine efficacy against tuberculosis","volume":"289","author":"Das","year":"2014","journal-title":"J Biol Chem"},{"key":"48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00345-009-0492-z","article-title":"Tumor-associated macrophages in clear cell renal cell carcinoma express both gastrin-releasing peptide and its receptor: a possible modulatory role of immune effectors cells","volume":"28","author":"Heuser","year":"2010","journal-title":"World J Urol"},{"key":"49","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2407-12-306","article-title":"The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients","volume":"12","author":"Leandersson","year":"2012","journal-title":"BMC Cancer"},{"key":"50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/01913123.2012.728688","article-title":"Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy","volume":"37","author":"Boubaker","year":"2013","journal-title":"Ultrastruct Pathol"},{"key":"52","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.juro.2008.11.090","article-title":"Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinomaafter intravesical bacillus Calmette-Guerin instillation","volume":"181","author":"Nonomura","year":"2009","journal-title":"J Urol"},{"key":"53","first-page":"449","article-title":"The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure","volume":"32","author":"Santos","year":"2014","journal-title":"Urol Oncol"},{"key":"54","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.eururo.2009.01.040","article-title":"Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"55","author":"Fradet","year":"2009","journal-title":"Eur Urol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T21:14:03Z","timestamp":1589231643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,21]]},"references-count":54,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2016,6,28]]}},"alternative-id":["9537","27221038"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9537","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,21]]}}}